{Reference Type}: Journal Article
{Title}: Morphine acts in vitro to directly prime nociceptors.
{Author}: Khomula EV;Levine JD;
{Journal}: Mol Pain
{Volume}: 20
{Issue}: 0
{Year}: 2024 Jan-Dec
{Factor}: 3.37
{DOI}: 10.1177/17448069241260348
{Abstract}: Hyperalgesic priming is a preclinical model of the transition from acute to chronic pain characterized by a leftward shift in the dose-response curve for and marked prolongation of prostaglandin E2 (PGE2)-induced mechanical hyperalgesia, in vivo. In vitro, priming in nociceptors is characterized by a leftward shift in the concentration dependence for PGE2-induced nociceptor sensitization. In the present in vitro study we tested the hypothesis that a mu-opioid receptor (MOR) agonist opioid analgesic, morphine, can produce priming by its direct action on nociceptors. We report that treatment of nociceptors with morphine, in vitro, produces a leftward shift in the concentration dependence for PGE2-induced nociceptor sensitization. Our findings support the suggestion that opioids act directly on nociceptors to induce priming.